Calamos Advisors’s Ingevity NGVT Stock Holding History

Calamos Advisors’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-59,200	Closed	-$4.82M	–	1027
2021 Q2	$4.82M	Buy	+59,200	New	+$4.76M	0.02%	584
2021 Q1	–	Sell	-39,051	Closed	-$2.96M	–	943
2020 Q4	$2.96M	Buy	+39,051	New	+$2.54M	0.02%	585
2020 Q1	–	Sell	-45,829	Closed	-$4M	–	764
2019 Q4	$4M	Buy	45,829 +14,128	+45%	+$1.24M	0.02%	552
2019 Q3	$2.69M	Sell	31,701 -63,407	-67%	-$5.65M	0.01%	591
2019 Q2	$10M	Buy	95,108 +90,418	+1,928%	+$9.09M	0.06%	339
2019 Q1	$495K	Buy	4,690 +865	+23%	+$86.9K	﹤0.01%	600
2018 Q4	$320K	Sell	3,825 -600	-14%	-$54.3K	﹤0.01%	617
2018 Q3	$451K	Buy	+4,425	New	+$427K	﹤0.01%	596

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

ICP

Inclusive Capital Partners San Francisco, California $26M AUM 22.24% 1-Year Est. Return

AAM

Ardevora Asset Management London, United Kingdom $1.12B AUM 26.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Calamos Advisors's NGVT Position: Q3 2021 in Review

Calamos Advisors sold out of Ingevity (NGVT) in Q3 2021, closing a stake of 59,200 shares — an estimated $4.82M sold.

Calamos Advisors first reported a position in NGVT in Q3 2018 and held it in 8 quarters. The position peaked at $10M in Q2 2019. 277 funds tracked by Wall St. Rank hold NGVT as of Q3 2021.

Calamos Advisors reported no remaining Ingevity position as of Q3 2021 after selling out during the quarter.
Calamos Advisors sold 59,200 Ingevity shares in Q3 2021, an estimated $4.82M.
Calamos Advisors first reported a position in Ingevity in Q3 2018 and held it in 8 quarters.
Calamos Advisors's Ingevity position peaked at $10M in Q2 2019.
277 funds tracked by Wall St. Rank held Ingevity as of Q3 2021.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.